Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

October 3, 2022

Gadolinium-based contrast agent exposures and physical and cognitive disability in multiple sclerosis

  • MRI
    /
 Kunio Nakamura 1, Marisa P McGinley 2, Stephen E Jones 3, Mark J Lowe 3, Jeffrey A Cohen 2, Paul M Ruggieri 3, Daniel Ontaneda 2 Affiliations expand PMID: 36181666   DOI: 10.1111/jon.13057 Abstract Background and…
MRI

October 3, 2022

Let’s Learn about a New MS Treatment – with Nurse Practitioner Katrina M. Bawden, MSN, MSCN, NP-C.

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
  Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews…
MS Drug Therapies

September 30, 2022

Off-label DMT Use for Progressive MS May Be as Effective as On-label

  • MS Drug Therapies
    /
 by Lindsey Shapiro, PhD | September 7, 2022 ‘Small’ difference in disability worsening at 2 years seen across 5 trials…
MS Drug Therapies

September 30, 2022

IFN-beta Therapy Found to Help Blood Vessels in Brain Dilate in MS

  • MS Drug Therapies
    /
by Vanda Pinto, PhD | September 30, 2022 DMT restores cerebrovascular reactivity that’s reduced in patients: study Treatment with interferon beta (IFN-beta) —…
MS Drug Therapies

September 30, 2022

How Many Times a Day Should You Pee?

  • Aging & MS
    /
  • Misc. MS Related
    /
  • Urologic Symptoms
    /
 The Unmentionables is a series that answers common questions we all have about our bodies but are sometimes afraid to…
Aging & MS

September 28, 2022

Unhealthy Coping Strategies in MS May Lead to Worse Quality of Life

  • Additional MS resource sites
    /
  • Healthcare Perspectives
    /
  • Misc. MS Related
    /
 New study recommends ‘regular supervision’ of patients’ coping methods article written by: Lindsey Shapiro, PhD  – Sept 26, 2022 ———————————— People…
Additional MS resource sites

September 28, 2022

Guerbet Announces FDA Approval of Elucirem (Gadopiclenol) for Use in Contrast-enhanced MRI

  • MRI
    /
 Guerbet, a global medical imaging company, has announced that the U.S. Food and Drug Administration (FDA) after priority review, approved…
MRI

September 28, 2022

How MS progresses over time / The Expanded Disability Status Scale and what this means

  • MRI
    /
  • Multiple Sclerosis
    /
 Most people with MS experience two stages of disease. The first stage is relapsing-remitting MS (RRMS), which is characterized by episodes of…
MRI

September 27, 2022

Dual Cognitive, Motor Tasks More Difficult Even in Early MS Stages

  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
 Dual-tasking cognitive and motor problems seen with mild, moderate disease September 27, 2022 Even in early stages of disease, people…
Multiple Sclerosis

September 26, 2022

Survival Much Higher for MS Patients Who Take DMTs as Directed: Study

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
 Medication adherence linked to greater survival for US veterans prescribed DMTs by Marisa Wexler, MS | September 23, 2022 The likelihood of survival…
MS Drug Therapies

Categories

Latest Blog Posts